In a filing, Blueprint Medicines Corp revealed its Director COATS LONNEL unloaded Company’s shares for reported $0.94 million on Nov 20 ’24. In the deal valued at $93.77 per share,10,000 shares were sold. As a result of this transaction, COATS LONNEL now holds 12,066 shares worth roughly $1.14 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, COATS LONNEL sold 9,824 shares, generating $932,003 in total proceeds. Upon selling the shares at $94.87, the Director now owns 2,242 shares.
Before that, LONNEL COATS bought 9,824 shares. Blueprint Medicines Corp shares valued at $931,413 were divested by the Director at a price of $94.81 per share.
JP Morgan initiated its Blueprint Medicines Corp [BPMC] rating to an Overweight in a research note published on November 14, 2024; the price target was $126. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Neutral”‘ rating. Stephens began covering BPMC with “an Overweight” recommendation on May 14, 2024. Leerink Partners revised its rating on May 06, 2024. It rated BPMC as “a Market perform” which previously was an “an Underperform”.
Price Performance Review of BPMC
On Friday, Blueprint Medicines Corp [NASDAQ:BPMC] saw its stock fall -2.56% to $94.15. Over the last five days, the stock has gained 6.16%. Blueprint Medicines Corp shares have risen nearly 2.07% since the year began. Nevertheless, the stocks have risen 40.50% over the past one year. While a 52-week high of $121.90 was reached on 07/16/24, a 52-week low of $65.68 was recorded on 02/14/24. SMA at 50 days reached $90.36, while 200 days put it at $96.10.
Levels Of Support And Resistance For BPMC Stock
The 24-hour chart illustrates a support level at 92.73, which if violated will result in even more drops to 91.30. On the upside, there is a resistance level at 96.96. A further resistance level may holdings at 99.76. The Relative Strength Index (RSI) on the 14-day chart is 52.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.65%. Stochastics %K at 46.98% indicates the stock is a holding.
How much short interest is there in Blueprint Medicines Corp?
A steep rise in short interest was recorded in Blueprint Medicines Corp stocks on 2024-10-31, growing by 0.6 million shares to a total of 4.13 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.53 million shares. There was a rise of 14.62%, which implies that there is a positive sentiment for the stock.
